Related Experiment Video
Updated: Jun 28, 2025
06:29
Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
2.3K
The Long COVID Symptoms and Severity Score: Development, Validation, and Application.
Gengchen Ye1, Yanan Zhu2, Wenrui Bao3
1Department of Medical Imaging, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
Summary
A new Long COVID Symptoms and Severity Score (LC-SSS) offers a standardized method for assessing long COVID patients. This validated tool identifies three distinct severity categories, enabling personalized treatment strategies and improved patient care.
Area of Science:
- Medical assessment tools
- Clinical research methodology
- Post-viral syndromes
Background:
- Long COVID presents diverse and persistent symptoms, necessitating standardized assessment tools.
- Current methods for evaluating long COVID severity lack standardization, hindering effective clinical management.
- A quantifiable tool is crucial for monitoring symptom progression and tailoring treatments for long COVID patients.
Purpose of the Study:
- To introduce and validate the Long COVID Symptoms and Severity Score (LC-SSS) as a clinical assessment tool.
- To establish a methodological framework for the clinical application of the LC-SSS.
- To develop standardized scoring for the LC-SSS to stratify patients by symptom severity.
Main Methods:
- The LC-SSS was developed and validated through a 3-stage process.
- Validation included correlation with established patient-reported outcome measures, confirmatory factor analysis, and reliability testing (Cronbach's α, test-retest).
- K-means clustering was employed to establish scoring standards and identify severity categories.
Main Results:
- The LC-SSS demonstrated strong construct validity through correlations with multiple established scales (e.g., PHQ-9, BAI, ISI).
- Excellent internal consistency (Cronbach's α = 0.93) and satisfactory test-retest reliability (ICC = 0.732) were confirmed.
- K-means clustering identified three distinct severity categories for long COVID patients.
Conclusions:
- The LC-SSS is a robust and validated instrument for assessing long COVID.
- The identified severity categories provide a basis for personalized treatment approaches.
- Implementation of the LC-SSS can enhance care quality for individuals experiencing long COVID.
